Internal Medicine · Seaford, DE
NPI
1700036241
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1501 Middleford Rd
Seaford, DE, 19973
Phone (302) 629-4569
Groups this clinician bills Medicare through
Medicare paid, 2024
$319K
3,525 services
Medicare patients, 2024
831
Average age 75
Drug cost, 2024
$2.8M
20,166 prescriptions
Company payments, 2025
$1,333
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark A Evangelista was code 99214 (office e&m - established), 2,283 times for 784 patients. In total Mark A Evangelista billed 3,525 services in 22 codes, and Medicare paid $319K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 2,283 | 784 | $86.27 | $197K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 614 | 614 | $125.82 | $77K |
| 99213 Office E&M - Established | Office | 350 | 300 | $56.61 | $20K |
| 90677 Vaccine Product | Office | 41 | 41 | $288.72 | $12K |
| G0008 Administration of influenza virus vaccine | Office | 40 | 40 | $31.89 | $1,276 |
| G0009 Administration of pneumococcal vaccine | Office | 39 | 39 | $31.89 | $1,244 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 28 | 28 | $161.51 | $4,522 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 24 | 24 | $12.81 | $307 |
| 90653 Vaccine Product | Office | 23 | 23 | $81.82 | $1,882 |
| 99204 Office E&M - New | Office | 20 | 20 | $105.79 | $2,116 |
| G0136 Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes | Office | 16 | 16 | $10.20 | $163 |
| 90656 Vaccine Product | Office | 16 | 16 | $21.90 | $350 |
By year: 2022 $326K for 3,785 services; 2023 $327K for 3,618 services; 2024 $319K for 3,525 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark A Evangelista prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,441 prescriptions and refills. In total Mark A Evangelista wrote 20,166 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,441 | 4,105 | 402 | $19K |
| Rosuvastatin Calcium Generic | 993 | 2,834 | 294 | $25K |
| Amlodipine Besylate Generic | 865 | 2,500 | 250 | $7,735 |
| Hydrochlorothiazide Generic | 607 | 1,799 | 176 | $2,913 |
| Metoprolol Succinate Generic | 566 | 1,592 | 158 | $9,339 |
| Losartan Potassium Generic | 527 | 1,523 | 145 | $5,628 |
| Metformin Hcl Er Metformin Hcl | 519 | 1,472 | 150 | $6,657 |
| Levocetirizine Dihydrochloride Generic | 475 | 1,281 | 160 | $11K |
| Levothyroxine Sodium Generic | 471 | 1,254 | 111 | $4,426 |
| Lisinopril Generic | 470 | 1,395 | 131 | $4,341 |
| Ozempic Semaglutide | 393 | 594 | 89 | $564K |
| Tamsulosin Hcl Generic | 373 | 1,062 | 107 | $5,840 |
| Famotidine Generic | 368 | 1,045 | 114 | $6,358 |
| Omeprazole Generic | 351 | 918 | 112 | $5,444 |
| Metformin Hcl Generic | 338 | 976 | 89 | $2,722 |
Brand drugs: 2,483 claims; generic drugs: 17,598 claims; opioid claims: 173.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark A Evangelista $1,333 ($1,333 in general payments such as food, travel and fees) from 16 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $274.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 13 | $274 |
| Novo Nordisk Inc NVO | 17 | $232 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 21 | $184 |
| GlaxoSmithKline, LLC. GSK | 6 | $103 |
| Exact Sciences Corporation EXAS | 4 | $91.8 |
| Abbvie Inc. ABBV | 5 | $86.05 |
| Pfizer Inc. PFE | 4 | $71.71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $45.87 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $43.37 |
| Tactile Systems Technology Inc TCMD | 2 | $41.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.